314930 — Biodyne Co Balance Sheet
0.000.00%
- KR₩424bn
- KR₩404bn
- KR₩5bn
Annual balance sheet for Biodyne Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,984 | 25,461 | 20,735 | 19,726 | 20,713 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,545 | 1,055 | 605 | 754 | 1,141 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6,690 | 27,987 | 22,915 | 21,134 | 22,361 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 10,639 | 11,310 | 11,531 | 11,293 | 10,836 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 25,245 | 45,823 | 45,414 | 43,986 | 44,347 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5,578 | 7,313 | 1,254 | 604 | 1,148 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 18,242 | 7,324 | 1,255 | 604 | 1,148 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 7,002 | 38,498 | 44,159 | 43,382 | 43,200 |
| Total Liabilities & Shareholders' Equity | 25,245 | 45,823 | 45,414 | 43,986 | 44,347 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |